Brenda de Winter

Hospital Pharmacist - Assistant Professor

Erasmus University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Marlies Reinders

Erasmus University Rotterdam

NETHERLANDS

View details

Dirk Jan A. R. Moes

Leiden University Medical Center

NETHERLANDS

View details

Kirsten J. M. Schimmel

NETHERLANDS

View details

Daniel Bos

Erasmus University Rotterdam

NETHERLANDS

View details

Erik Wilms

Head of Laboratory

NETHERLANDS

View details

Nynke Wijbenga

Erasmus University Rotterdam

NETHERLANDS

View details

Vincent ARANZANA-CLIMENT

Associate Professor

University of Poitiers

FRANCE

View details

Merel Hellemons

Erasmus University Rotterdam

NETHERLANDS

View details

Henk-Jan Guchelaar

Leiden University Medical Center

NETHERLANDS

View details

Midas B. Mulder

NETHERLANDS

View details

Anouk Muller

department of pathology erasmus university medical center rotterdam the netherlands

NETHERLANDS

View details

Teun van Gelder

Professor in Drug Discovery & Development

Leiden University Medical Center

NETHERLANDS

View details

Ron Keizer

Chief Scientific Officer

UNITED STATES

View details

Sanne van den Berg

assistant professor

Erasmus MC

NETHERLANDS

View details

Jesse Swen

Full professor of clinical pharmacy, in particular translational pharmacogenetics

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brenda de Winter

Research Interests

Explore related searches

Articles (18)

Dose Individualisation of Antimicrobials from a Pharmacometric Standpoint: The Current Landscape

Model-informed dose optimization of mycophenolic acid in pediatric kidney transplant patients

Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy

Prediction of the Intra‐T Lymphocyte Tacrolimus Concentration after Kidney Transplantation with Population Pharmacokinetic Modeling

Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults

Removing the physician from the equation: Patient‐controlled, home‐based therapeutic drug self‐monitoring of tacrolimus

Subtherapeutic triazole concentrations as result of a drug-drug interaction with lumacaftor/ivacaftor

Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia

Development and Bioequivalence of 3D‐Printed Medication at the Point‐of‐Care: Bridging the Gap Toward Personalized Medicine

Diagnostic accuracy of eNose ‘breathprints’ for therapeutic drug monitoring of Tacrolimus trough levels in lung transplantation

Oral antibiotics lower mycophenolate mofetil drug exposure, possibly by interfering with the enterohepatic recirculation: A case series

Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection models

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain-Barré Syndrome.

High-throughput analysis for the simultaneous quantification of nine beta-lactam antibiotics in human plasma by UPC<sup>2</sup>-MS/MS: Method development, validation, and clinical application.

Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice.

Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients.

A Population Pharmacokinetic Model of Whole-Blood and Intracellular Tacrolimus in Kidney Transplant Recipients.

RE: Efficacy and safety of IV sildenafil in the treatment of newborn infants with, or at risk of persistent pulmonary hypertension of the newborn (PPHN): A multicenter, randomized, placebo-controlled trial.

Collaborators (15)

Marlies Reinders

Dirk Jan A. R. Moes

Kirsten J. M. Schimmel

Daniel Bos

Erik Wilms

Nynke Wijbenga

Vincent ARANZANA-CLIMENT

Merel Hellemons

Henk-Jan Guchelaar

Midas B. Mulder

Anouk Muller

Teun van Gelder

Ron Keizer

Sanne van den Berg

Jesse Swen

Make your next move.